We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Industry

Image: The integration is expected to enable approximately 450 health systems to deliver Galleri results within their existing patient portals (photo courtesy of GRAIL)

GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR

A new EHR integration embeds an multi-cancer early detection (MCED) blood test for point-of-care ordering and results. More...
08 Apr 2026
Image: The collaboration pairs Pillar’s oncoReveal kitted NGS panels with CellCarta’s global laboratory network and biomarker expertise (photo courtesy of Pillar Biosciences)

Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials

CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership to broaden access to operationally streamlined NGS tumor profiling for biopharma sponsors and clinical research partners worldwide. More...
07 Apr 2026
Image: The collaboration focuses on verified automation methods for Takara Bio USA’s SMART-Seq library preparation kits on Hamilton’s Microlab STAR Liquid Handling Systems (photo courtesy of Hamilton Company)

Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated NGS library preparation workflows. More...
01 Apr 2026
Image: The partnership combines Lunit’s platform-agnostic AI pathology algorithms with CellCarta’s global CDx development and laboratory execution (photo courtesy of Lunit)

Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development

Lunit and CellCarta have announced a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows across translational research, clinical trials and CDx programs. More...
31 Mar 2026
Image: The assays run on the cobas i 601 analyzer as part of the cobas Mass Spec solution (photo courtesy of Roche)

New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

Roche’s Ionify® steroid assays are its latest mass spectrometry tests to receive CLIA ‘moderate complexity’ classification. More...
30 Mar 2026
Image: The assay serves as an adjunctive tool in evaluating patients suspected of B-cell lymphoproliferative disorders (photo courtesy of Shutterstock)

First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

Invivoscribe's IdentiClone Dx IGH Assay is the first IVDR-certified assay for IGH clonality detection in patients with suspected B-cell lymphoproliferative disease. More...
30 Mar 2026
Image: IDT’s Archer IVD Assay portfolio is built on easy-to-use Anchored Multiplex PCR technology (photo courtesy of IDT)

Integrated DNA Technologies Expands into Clinical Diagnostics

Integrated DNA Technologies (IDT) has announced the launch of the company’s first IVD offerings and its strategic entry into the NGS IVD market. More...
26 Mar 2026
New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Immunofluorescence Analyzer
IFA System


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.